Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: A randomized, controlled trial

Journal of the American Heart Association

Volumn 4, Issue 1, 2015, Pages

  Wang, Li ^a   Bordi, Peter L ^a   Fleming, Jennifer A ^a   Hill, Alison M ^b   Kris Etherton, Penny M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Avocados; Cardiovascular disease; Diet; Fatty acids; Lipids; Lipoproteins; MUFA

Indexed keywords

CANOLA OIL; CARBOHYDRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; SATURATED FATTY ACID; SUNFLOWER OIL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; AVOCADO; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CHOLESTEROL DIET; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; FEMALE; FOOD INTAKE; HUMAN; LIPID ANALYSIS; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MACRONUTRIENT; MALE; MODERATE FAT DIET; OBESITY; PARTICLE SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; BODY MASS; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DIET THERAPY; FOLLOW UP; MIDDLE AGED; PERSEA; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-OVER STUDIES; DIET, FAT-RESTRICTED; FATTY ACIDS, MONOUNSATURATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PARTICLE SIZE; PERSEA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85016650335     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.001355     Document Type: Article

References (51)

1. Eckel RH, Jakicic JM, Ard JD, Miller NH, Hubbard VS, Nonas CA, de Jesus JM, Sacks FM, Lee I-M, Lichtenstein AH, Loria CM, Millen BE, Miller NH, Nonas CA, Sacks FM, Smith SC Jr, Svetkey LP, Wadden TW, Yanovski SZ. AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the ACC/AHA task force on practice guidelines. Circulation. 2013;2013:1524-4539.
2. Moreno JJ, Mitjavila MT. The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review). J Nutr Biochem. 2003;14:182-195.
3. Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279-1290.
4. Dreher ML, Davenport AJ. Hass avocado composition and potential health effects. Crit Rev Food Sci Nutr. 2012;53:738-750.
5. Carranza-Madrigal J, Herrera-Abarca JE, Alvizouri-Muoz M, Alvarado-Jimenez MR, Chavez-Carbajal F. Effects of a vegetarian diet vs. A vegetarian diet enriched with avocado in hypercholesterolemic patients. Arch Med Res. 1997;28:537-542.
6. López Ledesma R, Frati Munari AC, Hernández Domínguez BC, Cervantes Montalvo S, Hernández Luna MH, Juárez C, Morán Lira S. Monounsaturated fatty acid (avocado) rich diet for mild hypercholesterolemia. Arch Med Res. 1996;27:519-523.
7. Carranza J, Alvizouri M, Alvarado M, Chavez F, Gomez M, Herrera J. Effects of avocado on the level of blood lipids in patients with phenotype II and IV dyslipidemias. Arch Inst Cardiol Mex. 1995;65:342-348.
8. Lerman-Garber I, Ichazo-Cerro S, Zamora-González J, Cardoso-Saldaña G, Posadas-Romero C. Effect of a high-monounsaturated fat diet enriched with avocado in NIDDM patients. Diabetes Care. 1994;17:311-315.
9. Colquhoun D, Moores D, Somerset SM, Humphries JA. Comparison of the effects on lipoproteins and apolipoproteins of a diet high in monounsaturated fatty acids, enriched with avocado, and a high-carbohydrate diet. Am J Clin Nutr. 1992;56:671-677.
10. Alvizouri-Muñoz M, Carranza-Madrigal J, Herrera-Abarca J, Chavez-Carbajal F, Amezcua-Gastelum J. Effects of avocado as a source of monounsaturated fatty acids on plasma lipid levels. Arch Med Res. 1992;23:163-167.
11. Pieterse Z, Jerling J, Oosthuizen W, Kruger H, Hanekom S, Smuts C, Schutte A. Substitution of high monounsaturated fatty acid avocado for mixed dietary fats during an energy-restricted diet: effects on weight loss, serum lipids, fibrinogen, and vascular function. Nutrition. 2005;21:67-75.
12. Grant WC. Influence of avocados on serum cholesterol. Proc Soc Exp Biol Med. 1960;104:45-47.
13. US Department of Health and Human Services and the US Department of Agriculture. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010;PartD.
14. Kulkarni K. Cholesterol profile measurement by vertical auto profile method. Clin Lab Med. 2006;26:787-802.
15. Otvos JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab. 2001;48:171-180.
16. Gebauer SK, West SG, Kay CD, Alaupovic P, Bagshaw D, Kris-Etherton PM. Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study. Am J Clin Nutr. 2008;88:651-659.
17. Stone NJ, Robinson J, Lichtenstein AH, Merz CNB, Lloyd-Jones DM, Blum CB, McBride P, Eckel RH, Schwartz JS, Goldberg AC. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults - a report of the ACC/AHA task force on practice guidelines. J Am Coll Cardiol. 2013;2013:1524-4539.
18. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Bälter K, Fraser GE, Goldbourt U, Hallmans G, Knekt P, Liu S. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89:1425-1432.
19. Hirasawa M, Shimura K, Shimizu A, Mura K, Tokue C, Arai S. Quantification and functional analysis of dietary fiber and polyphenols in avocado [Persea americana]. J Jpn Soc Food Sci Technol. 2008;55:95-101.
20. Ladrière L, Leclercq-Meyer V, Malaisse WJ. Assessment of islet ß-cell mass in isolated rat pancreases perfused with D-[3 h] mannoheptulose. Am J Physiol Endocrinol Metab. 2001;281:E298-E303.
21. Liu X, Sievert J, Arpaia ML, Madore MA. Postulated physiological roles of the seven-carbon sugars, mannoheptulose, and perseitol in avocado. J Am Soc Hortic Sci. 2002;127:108-114.
22. Sialvera T, Pounis G, Koutelidakis A, Richter D, Yfanti G, Kapsokefalou M, Goumas G, Chiotinis N, Diamantopoulos E, Zampelas A. Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet. Nutr Metab Cardiovasc Dis. 2011;22:843-848.
23. Lamarche B, Desroches S, Jenkins DJ, Kendall CW, Marchie A, Faulkner D, Vidgen E, Lapsley KG, Trautwein EA, Parker TL. Combined effects of a dietary portfolio of plant sterols, vegetable protein, viscous fibre and almonds on LDL particle size. Br J Nutr. 2004;92:657-663.
24. Davy BM, Davy KP, Ho RC, Beske SD, Davrath LR, Melby CL. High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men. Am J Clin Nutr. 2002;76:351-358.
25. Gill JM, Brown JC, Caslake MJ, Wright DM, Cooney J, Bedford D, Hughes DA, Stanley JC, Packard CJ. Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL. Am J Clin Nutr. 2003;78:47-56.
26. Kratz M, Gülbahçe E, von Eckardstein A, Cullen P, Cignarella A, Assmann G, Wahrburg U. Dietary mono-and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J Nutr. 2002;132:715-718.
27. Rivellese AA, Maffettone A, Vessby B, Uusitupa M, Hermansen K, Berglund L, Louheranta A, Meyer BJ, Riccardi G. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis. 2003;167:149-158.
28. Damasceno NR, Sala-Vila A, Cofán M, Pérez-Heras AM, Fitó M, Ruiz-Gutiérrez V, Martínez-González M-Á, Corella D, Arós F, Estruch R. Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk. Atherosclerosis. 2013;230:347-353.
29. Almario RU, Vonghavaravat V, Wong R, Kasim-Karakas SE. Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am J Clin Nutr. 2001;74:72-79.
30. Holligan SD, West SG, Gebauer SK, Kay CD, Kris-Etherton PM. A moderate-fat diet containing pistachios improves emerging markers of cardiometabolic syndrome in healthy adults with elevated LDL levels. Br J Nutr. 2014;112:744-752.
31. Williams PT, Zhao X-Q, Marcovina SM, Brown BG, Krauss RM. Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident chd in the HDL-atherosclerosis treatment study (HATS). PLoS One. 2013;8:e56782.
32. Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, Cupples LA, Wilson PW, Schaefer EJ. Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clin Chem. 2010;56:967-976.
33. Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E. Small dense low-density lipoproteincholesterol concentrations predict risk for coronary heart disease the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vac Biol. 2014;34:1069-1077.
34. Tsai MY, Steffen BT, Guan W, McClelland RL, Warnick R, McConnell J, Hoefner DM, Remaley AT. New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease in the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vac Biol. 2014;34:196-201.
35. Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, Wilson PW, D'Agostino RB. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-implications for LDL management. J Clin Lipidol. 2007;1:583-592.
36. Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol. 2011;5:105-113.
37. Mora S, Buring JE, Ridker PM. Discordance of LDL cholesterol with alternative LDL-related measures and future coronary events. Circulation. 2014;129:553-561.
38. Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, Arakaki R, Watson K, Horton E, Barrett-Connor E. Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the diabetes prevention program. J Clin Endocrinol Metab. 2013;98:3989-3998.
39. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype A proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495-506.
40. Richard C, Couture P, Ooi EM, Tremblay AJ, Desroches S, Charest A, Lichtenstein AH, Lamarche B. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome. Arterioscler Thromb Vac Biol. 2014;34:433-438.
41. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A1 and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326-333.
42. Packard C, Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb. 2003;11:6-14.
43. Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch K. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307:1302-1309.
44. Nakamura T, Obata J-E, Hirano M, Kitta Y, Fujioka D, Saito Y, Kawabata K-I, Watanabe K, Watanabe Y, Mishina H. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals. Atherosclerosis. 2011;218:163-167.
45. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 1999;99:2858-2860.
46. Mackey RH, Greenland P, Goff DC, Lloyd-Jones D, Sibley CT, Mora S. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events in MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2012;60:508-516.
47. Sola R, Motta C, Maille M, Bargallo M, Boisnier C, Richard J, Jacotot B. Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb. 1993;13:958-966.
48. Kontush A, Chapman MJ. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol. 2010;21:312-318.
49. Davidson WS, Silva RGD, Chantepie S, Lagor WR, Chapman MJ, Kontush A. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters relevance to antioxidative function. Arterioscler Thromb Vac Biol. 2009;29:870-876.
50. De Souza JA, Vindis C, Nègre-Salvayre A, Rye KA, Couturier M, Therond P, Chantepie S, Salvayre R, Chapman MJ, Kontush A. Small, dense HDL3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. J Cell Mol Med. 2010;14:608-620.
51. Landers PS, Landers TL. Survival analysis of dropout patterns in dieting clinical trials. J Am Diet Assoc. 2004;104:1586-1588.